SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as investors react to a wave of news, including an increased financial outlook, a new enterprise data security agreement, and the unveiling of its sixth-generation quantum computer, Superion 256. While some traders are bullish on the company's roadmap and upcoming investor event, others express skepticism regarding valuation and the long-term path to profitability.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending primarily due to a multi-generational collaboration with Amazon to develop customized silicon for AI data centers and optical connectivity solutions, alongside a warrant agreement involving 25 million shares tied to server-chip milestones.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

The community is debating the stock's long-term value and buyout potential, with many traders expressing frustration over stagnant price action and low volume. While some investors remain optimistic about future pipeline catalysts and Orladeyo's performance, others are heavily criticizing management and speculating on potential M&A activity.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to the company securing a $100 million U.S. Department of Commerce funding agreement under the CHIPS Act. While some traders view the government backing as a major catalyst for quantum computing R&D, community sentiment remains mixed with debates regarding the stock's valuation, insider selling, and potential for a short squeeze.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are gaining momentum ahead of the company's upcoming earnings report, driven by optimistic analyst target increases and excitement surrounding its AI infrastructure positioning. Traders are debating the sustainability of the stock's recent rally, with many anticipating a significant move following the results while weighing the risks of volatility and potential short squeezes.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is currently trending as traders discuss the company's convertible note exchange and potential share buybacks, while debating the impact of ongoing volatility and short interest. The community remains divided, with some investors expressing frustration over recent price stagnation and lack of corporate communication, while others view the current valuation as an accumulation opportunity ahead of upcoming earnings.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending following a lawsuit filed by the Federal Trade Commission and multiple states alleging the company misled advertisers and manipulated ad auction pricing. Traders are divided between concerns over potential long-term legal liability and viewing the resulting dip as an opportunity to buy.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently a focal point for investors due to its position near 52-week lows, with the community divided between those viewing the stock as a discounted blue-chip opportunity and those concerned about bearish technical trends and shifting consumer behavior. Traders are actively debating the impact of macroeconomic factors, such as beef supply chain dynamics, versus the long-term potential of the company's real estate-heavy business model.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trading lower following the failure of a Phase 3 trial for a competitor's DM1 drug, which has fueled speculation among traders about the potential read-through risk for the company's own clinical programs and overall pipeline viability. While some investors view the sell-off as an excessive knee-jerk reaction driven by algorithmic selling and are looking for buying opportunities, others remain cautious regarding the implications of the competitor's failure for the broader space.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending following an escalation in the conflict between the U.S. and Iran, triggered by new U.S. military strikes on Iranian assets near the Strait of Hormuz. While some traders are betting on a continued surge in prices due to supply disruption fears, others argue that market reaction remains speculative and anticipate potential de-escalation or price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novartis is trending as investors react to the company's decision to pause several clinical trials of an experimental cell therapy following three patient deaths, while simultaneously announcing positive Phase III trial results for a multiple sclerosis treatment.

Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners

Novartis stock falls following Phase 3 clinical trial failures for del-desiran and pelacarsen, impacting Ionis and Royalty Pharma shares.read more...

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen's Phase III trial missed its endpoint; other biotech stocks also declined.read more...

Novartis twin drug setbacks pile pressure on pipeline and CEO

Novartis twin drug setbacks pile pressure on pipeline and CEO...

Attacks Halt Saudi Energy Sites, Novartis Drops Most in 6 Years  The Opening Trade 9/8/2026

Attacks Halt Saudi Energy Sites, Novartis Drops Most in 6 Years | The Opening Trade 9/8/2026...

Pharma major plummets over 10% after third trial disappointment in a week

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors...

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey's earnings expected.read more...

Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down 

Novartis' pelacarsen study failed to cut cardiovascular events, clouding prospects for the drug and highlighting portfolio challenges.

Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal

AMGN shares fall as NVS' pelacarsen setback casts investor concern over whether olpasiran can deliver positive phase III outcome data.

Futures Drop As Iran Hostilities Send Brent To 6 Week High Above $97

Futures Drop As Iran Hostilities Send Brent To 6 Week High Above $97

 US stock futures slipped in cautious, low volume trading as the latest Middle East escalation pushed oil prices higher, lifting bond yields in Europe and Asia. As of 9:00am ET, S&P futures were down 0.2% with Nasdaq...

AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah

AZN's Etcamah wins accelerated FDA approval for certain advanced breast cancer patients, backed by a 56% risk reduction in progression or death.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff?

Equity

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Novartis AG

High-profile clinical trial failures in myotonic dystrophy and cardiovascular drugs have triggered a sector-wide investor selloff.

Multiple late-stage phase 3 trial flops are intensifying pressure on company leadership to secure new strategic acquisitions.

Recent clinical outcomes have stalled key cardiovascular development programs, leaving a significant void in the industry's heart-health pipelines.

Traders are actively betting on which smaller biotech firms might become takeover targets to bolster lagging large-cap pharma pipelines.

Current Price	$140.09
Prev Close	$159.99
Open	$140.01
Dividend Yield	2.23%
50-Day Moving Average	$155.62
Beta	0.25
Avg. Volume	1.39M
PE Ratio	23.99

52-Week High	$170.46
52-Week Low	$121.57
Market Capitalization	$292.87B
EPS (Annual)	$7.25
Price to Book	7.05
Revenue Per Employee	$728,224.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVS Fundamentals